Version July 2025
| Category | Marker (and commonly used abbreviation) | Evidence for outcome predictability in CKD* |
| Short pentraxins | C-reactive protein (CRP) | ++++ |
| Serum amyloid P (SAP) | ++ | |
| Long pentraxins | Pentraxin-3 (PTX3) | ++ |
| Neuronal pentraxins | ? | |
| Pro-inflammatory cytokines | Interleukin-6 (IL-6) | ++++ |
| Interleukin-1 beta (IL-1-beta) | + | |
| Tumor necrosis factor alpha (TNF-alpha) | +/- | |
| Interleukin-8 (IL-8) | + | |
| Interleukin-18 (IL-18) | ? | |
| Interleukin-12 (IL-12) | ? | |
| Interferon gamma (IFN-gamma) | + | |
| Anti-inflammatory cytokines | Interleukin-10 (IL-10) | ? |
| IL-1 receptor antagonist (IL-1ra) | + | |
| Interleukin-4 (IL-4) | ? | |
| Transforming growth factor beta (TGF-beta) | ? | |
| Adipokines and related compounds | Adiponectin | ++ |
| Visfatin | + | |
| Resistin | + | |
| Leptin | + | |
| CD163 | + | |
| Adhesion molecules and endothelial markers | Intercellular adhesion molecule-1 (ICAM-1) | ++ |
| Vascular cell adhesion molecule-1 (VCAM-1) | ++ | |
| E-selectin | + | |
| Coagulation markers | Fibrinogen | + |
| Tissue plasminogen activator (t-PA) | + | |
| Plasminogen activator inhibitor-1 [PAI-1]) | + | |
| von Willebrand factor (vWF) & factor VII | ? | |
| Fibrin D-dimer | ? | |
| Inflammatory molecules with negative acute phase reaction | Albumin (negative) | ++++ |
| Transferrin or TIBC | ++ | |
| Iron | ++ | |
| Fetuin | + | |
| Inflammatory lipoproteins | HDL inflammatory index (HII) | ++ |
| Oxidized LDL (oxLDL) | + | |
| Inflammatory enzymes | Myeloperoxidase (MPO) | + |
| Matrix metalloproteinase (MMP-9) | + | |
| Pro-inflammatory transcription factors | Activator protein-1 (AP-1) | + |
| Nuclear factor-kappa B (NF-κB) | + | |
| Other inflammatory markers | Serum ferritin | +++ |
| Serum amyloid A (SAA) | + | |
| Neopterin (monocyte/macrophage activator) | + | |
| Platelet count | +++ | |
| WBC count | ++ | |
| Neutrophil count | + | |
| Erythrocyte sedimentation rate (ESR) | + |
